Stock listing

LSE:0RA9 Abivax SA Share Price

UK listing (LSE) of Abivax SA · home listing Euronext:ABVX

Follow Abivax SA into a list and get an email when it puts out news.

Share price · LSE:0RA9

€75.15 EUR -1.75 (-2.3%)

Close on Nov 17, 2026

Past year -21.1% · daily closes, Nov 17, 2025 – Nov 6, 2026, adjusted for splits
Day range
€74.60 – €76.00 EURNov 17, 2026
Volume
2,062 sharesNov 17, 2026
Market cap
€834.7M EURAt the close on Nov 17, 2026 · price × 11.11M shares outstanding
52-week range
€60.70 – €139.00 EURLowest and highest trades, Nov 18, 2025 – Nov 17, 2026
Traded on an average day
€367,909 EURMedian day 800 shares · last 3 months, Aug 17, 2026 – Nov 6, 2026
Abivax SA logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Euronext:ABVX · Home€75.50 EUR-1.40 (-1.8%)128,059€75.20€76.15€74.25€76.90Close on Nov 17, 2026
NASDAQ:ABVX$82.10 USD-1.51 (-1.8%)1,372,710$82.86$84.31$81.83$83.61Close on Nov 17, 2026
LSE:0RA9€75.15 EUR-1.75 (-2.3%)2,062€76.00€76.00€74.60€76.90Close on Nov 17, 2026
OTC:AAVXF$84.80 USD0.00 (0.0%)—$84.80$84.80$84.80$84.80Close on Nov 6, 2026
Frankfurt:2X1€77.00 EUR+1.15 (+1.5%)101€74.65€77.00€74.65€75.85Close on Nov 17, 2026
Frankfurt:2X10€74.00 EUR-3.50 (-4.5%)40€74.00€74.00€74.00€77.50Close on Nov 17, 2026

Daily closes

Last 3 months, Aug 17, 2026 – Nov 6, 2026 · LSE:0RA9 · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€76.50+0.30+0.4%€74.45€76.50€73.902,082
€76.20-4.55-5.6%€80.85€82.80€76.201,456
€80.75+0.95+1.2%€79.60€80.75€79.601,015
€79.80+2.00+2.6%€75.50€80.05€75.3518,406
€77.80-1.25-1.6%€78.00€78.20€77.40332
€79.05-2.40-2.9%€80.30€80.30€78.008,009
€81.45+1.40+1.7%€80.35€82.50€80.35209
€80.05+0.15+0.2%€80.60€80.60€79.4015
€79.90+1.90+2.4%€77.65€79.95€77.40261
€78.00-0.55-0.7%€79.10€80.00€78.00754
€78.55-4.05-4.9%€81.45€81.45€78.0080
€82.60-1.75-2.1%€81.50€82.95€81.50848
€84.35+1.10+1.3%€83.25€85.60€83.25737
€83.25+5.15+6.6%€78.55€83.25€78.55601
€78.10-0.50-0.6%€79.80€79.80€73.003,519
€78.60-3.40-4.1%€82.45€82.60€78.6053
€82.00+4.50+5.8%€78.60€82.35€78.0020
€77.50+0.925+1.2%€77.50€77.50€77.50218
€76.58-0.825-1.1%€77.50€78.00€75.6014,272
€77.40-2.45-3.1%€78.55€78.75€77.4016
€79.85+2.75+3.6%€79.95€79.95€79.00112,933
€77.10-1.50-1.9%€76.80€77.45€75.9019,435
€78.60-1.95-2.4%€78.75€78.90€77.552,526
€80.55+0.25+0.3%€81.65€83.10€78.90275
€80.30-3.20-3.8%€83.25€83.40€80.0042
€83.50-0.65-0.8%€84.00€84.38€83.051,013
€84.15-3.90-4.4%€87.30€87.30€83.5510,295
€88.05+3.30+3.9%€85.95€88.05€85.252,380
€84.75+0.95+1.1%€84.50€86.30€84.502,369
€83.80+2.25+2.8%€80.85€83.85€79.852,137
€81.55-0.05-0.1%€83.40€83.40€81.0570
€81.60-2.35-2.8%€82.60€83.50€81.001,625
€83.95-2.50-2.9%€85.90€86.50€83.955,311
€86.45-4.20-4.6%€89.00€90.65€84.80297
€90.65-0.20-0.2%€92.30€92.75€90.451,263
€90.85-2.25-2.4%€94.05€94.05€90.851,635
€93.10+2.15+2.4%€90.95€93.10€89.55461
€90.95-2.25-2.4%€93.50€93.75€89.40579
€93.20-6.55-6.6%€98.30€98.30€92.55156
€99.75-1.55-1.5%€101.50€102.00€99.157,522
€101.30+0.90+0.9%€98.70€101.30€98.65845
€100.40-0.40-0.4%€104.40€104.80€100.404,429
€100.80+1.40+1.4%€101.50€101.50€100.801,425
€99.40+1.55+1.6%€98.05€99.50€98.00128
€97.85+0.65+0.7%€98.95€99.60€97.85735
€97.20-2.45-2.5%€98.30€98.90€97.20990
€99.65+2.90+3.0%€97.10€99.65€96.6031
€96.75+0.95+1.0%€98.05€98.65€96.75188
€95.80-1.25-1.3%€96.30€96.30€95.00478
€97.05-1.385-1.4%€97.40€98.05€96.5013,937
€98.44-1.655-1.7%€98.60€99.35€97.926,124
€100.09-0.509-0.5%€100.60€101.40€99.86443
€100.60-2.90-2.8%€100.80€101.80€99.80288
€103.50+5.20+5.3%€101.80€103.90€100.8069
€98.30-3.50-3.4%€99.00€99.15€97.455,713
€101.80+1.50+1.5%€101.80€102.20€100.50851
€100.30-3.10-3.0%€104.90€105.00€100.002,354
€103.40+0.30+0.3%€103.20€103.60€102.6038
€103.10-1.50-1.4%€105.10€105.40€103.10166
€104.60+1.90+1.9%€103.20€104.60€103.20379
Ticker
LSE:0RA9
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
LSE
Currency
EUR

What changed lately

Calls

Replays

  • Abivax (Euronext:ABVX) Q4 2023 Earnings Call

    Mon, Apr 08, 2024 · 8:30 AM ET

    Watch Transcript

Latest news

All Abivax SA news

Financings

  • Public offering of american Depositary Shares

    Jul 6, 2026

    Closed: US$920M raised · Leerink Partners +5

    Dealers: Leerink Partners (co-lead), Morgan Stanley (co-lead), Piper Sandler (co-lead), Guggenheim Securities (co-lead), LifeSci Capital, Van Lanschot Kempen

    Use of proceeds: Together with existing cash, to finance operations into the fourth quarter of 2029

    Closed Jul 6, 2026

  • Public offering of american Depositary Shares

    Jul 2, 2026

    Made bigger: about US$920M · US$125 a share · Leerink Partners +5

    Dealers: Leerink Partners (co-lead), Morgan Stanley & Co. LLC (co-lead), Piper Sandler & Co. (co-lead), Guggenheim Securities, LLC (co-lead), LifeSci Capital, Van Lanschot Kempen

    Use of proceeds: Potential US commercialization of obefazimod, clinical R&D mainly in ulcerative colitis and Crohn's disease, and general corporate purposes

    Announced Jun 30, 2026 · Made bigger Jul 1, 2026 · Made bigger Jul 2, 2026

  • Public offering of american Depositary Shares

    Jul 28, 2025

    Closed: US$747.5M raised · US$64 a share · Leerink Partners +5

    Dealers: Leerink Partners (co-lead), Piper Sandler & Co. (co-lead), Guggenheim Securities, LLC (co-lead), LifeSci Capital, BTIG, Van Lanschot Kempen

    Use of proceeds: Finance operations into the fourth quarter of 2027, giving 12 months of cash runway after the planned NDA submission for Ulcerative Colitis

    Announced Jul 23, 2025 · Update Jul 24, 2025 · Made bigger Jul 25, 2025 · Closed Jul 28, 2025

Read by 6ix AI from the company's releases

Decks

Abivax SA on 6ix

Sector
Health care
Industry
Biotechnology
News releases
30 in the last 12 months · 49 in all · newest Nov 2, 2026 · oldest 2025
Calls
1 call with a replay · 1 with a transcript · latest Apr 8, 2024
Decks
39 decks · latest July 2026

Where Abivax SA is listed

ListingExchangeCountryCurrency
Euronext:ABVX · Home listingEuronextFranceEUR
NASDAQ:ABVXNASDAQUnited StatesUSD
LS Exchange:A14UQCLS ExchangeGermanyEUR
gettex:2X1gettexGermanyEUR
LSE:0RA9 · This pageLSEUnited KingdomEUR
Xetra:2X1XetraGermanyEUR
Tradegate:2X1TradegateGermanyEUR
OTC:AAVXFOTCUnited StatesUSD
Lang & Schwarz:A14UQCLang & SchwarzGermanyEUR
Aquis:ABVXPAquisUnited KingdomEUR
Frankfurt:2X1FrankfurtGermanyEUR
gettex:2X10gettexGermanyEUR
BX Swiss:ABVXBX SwissSwitzerlandCHF
Dusseldorf:2X1DusseldorfGermanyEUR
Lang & Schwarz:A3EWCPLang & SchwarzGermanyEUR
Munich:2X1MunichGermanyEUR
Hamburg:2X1HamburgGermanyEUR
Aquis:ABVXPAquisUnited KingdomEUR
BOATS:ABVXBOATSUnited StatesUSD
Frankfurt:2X10FrankfurtGermanyEUR
LS Exchange:A3EWCPLS ExchangeGermanyEUR
Stuttgart:2X1StuttgartGermanyEUR
Turquoise:ABVXPTurquoiseUnited KingdomEUR
VIE:ABVXViennaAustriaEUR
Dusseldorf:2X10DusseldorfGermanyEUR
Hamburg:2X10HamburgGermanyEUR
Munich:2X10MunichGermanyEUR
Stuttgart:2X10StuttgartGermanyEUR
Tradegate:2X10TradegateGermanyEUR
Hanover:2X1HanoverGermanyEUR

Log in to ask 6ix AI your own questions about Abivax SA.